Naturbiogas Tværmose ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.3% 0.3% 0.3% 0.3% 0.3%  
Bankruptcy risk  14.4% 4.7% 3.8% 7.1% 8.6%  
Credit score (0-100)  16 45 49 33 27  
Credit rating  BB BBB BBB BBB BB  
Credit limit (kDKK)  -0.0 0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  -2.6 -11.5 1,177 -4,218 4,945  
EBITDA  -2.6 -45.1 -190 -13,398 -4,990  
EBIT  -2.6 -50.0 -270 -17,999 -15,781  
Pre-tax profit (PTP)  -2.7 -53.4 -301.4 -27,856.7 -38,960.8  
Net earnings  -2.7 -41.7 -215.3 -21,814.1 -30,480.3  
Pre-tax profit without non-rec. items  -2.7 -53.4 -301 -27,857 -38,961  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 8,108 56,239 240,470 272,436  
Shareholders equity total  -5.0 -28.7 -244 -22,058 -52,538  
Interest-bearing liabilities  0.0 7,251 41,362 258,704 342,889  
Balance sheet total (assets)  0.0 8,467 65,648 282,554 319,853  

Net Debt  -0.0 7,086 41,362 258,606 342,853  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -2.6 -11.5 1,177 -4,218 4,945  
Gross profit growth  0.0% -338.4% 0.0% 0.0% 0.0%  
Employees  0 0 2 9 10  
Employee growth %  0.0% 0.0% 0.0% 350.0% 11.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 8,467 65,648 282,554 319,853  
Balance sheet change%  0.0% 423,352,000.0% 675.3% 330.4% 13.2%  
Added value  -2.6 -45.1 -189.7 -17,919.3 -4,989.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 8,103 48,051 179,629 21,175  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2019/12
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 436.4% -22.9% 426.7% -319.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -35.8% -0.6% -0.7% -9.7% -4.7%  
ROI %  -113.8% -0.7% -1.1% -12.0% -5.2%  
ROE %  -67,575.0% -0.5% -0.6% -12.5% -10.1%  

Solidity 
2019
2019/12
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -100.0% 82.3% 10.3% -5.1% -12.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.1% -15,698.3% -21,805.0% -1,930.1% -6,871.2%  
Gearing %  0.0% -25,303.9% -16,955.0% -1,172.8% -652.6%  
Net interest  0 0 0 0 0  
Financing costs %  7.7% 0.1% 0.1% 6.6% 7.7%  

Liquidity 
2019
2019/12
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.3 0.2 0.1 0.1  
Current Ratio  0.0 0.3 0.2 0.1 0.1  
Cash and cash equivalent  0.0 164.7 0.0 97.8 36.3  

Capital use efficiency 
2019
2019/12
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -5.0 -954.3 -48,835.9 -262,527.7 -324,974.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -95 -1,991 -499  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -95 -1,489 -499  
EBIT / employee  0 0 -135 -2,000 -1,578  
Net earnings / employee  0 0 -108 -2,424 -3,048